Stipenda, a leading Employer of Record (EOR) and Professional Employer Organization (PEO) provider, today announced the appointment of David Epstein as Chief Operating Officer (COO), effective 1 January 2026
Emerging biotech firm debuts "Science & Shield" initiative, bridging the gap between advanced medical research and immediate humanitarian relief for the Ozarks.
Christie Schofield and Randy Herbertson bring leadership in healthcare access, innovation, and brand strategy to advance supportive cancer care nationwide.
Biobase, a healthcare data infrastructure company pioneering the first agentic operating system for clinical data, received a strategic investment from BJC Health that will position BJC as a center of excellence for deploying next-generation AI solutions.
Platform delivers real-world evidence data for pharmaceutical research, hospital systems, insurance carriers, and senior living operators—achieving 87-91% accuracy in neurological disease detection
Bridging the orbital care gap: As NASA reassesses ISS medical protocols, Diopter Labs reveals a shelf-stable "clinic-in-a-lens" built to stop space-flight emergencies before they require evacuation.
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP has Entered into a Joint Offering with neurocare Group for Neuroplastic Therapy Targeting Depression, PTSD and Other Mental Health Afflictions
VSee Health, Inc. (N A S D A Q: VSEE) $VSEE Reported Q3 Revenues Reach $3.98 Million, Up 19% Year-Over-Year with Clients Including NASA, U.S. Department of Health and Human Services, McKesson, DaVita and The Nation of Qatar
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) NRXP Also Reports Its Superior Preservative-Free IV Ketamine Now Submitted for FDA Abbreviated New Drug Application
Analyst D. Boral Targets NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP at $34 Per Share — Pioneering Breakthroughs in Treatment-Resistant Depression and Chronic Pain
Stipenda, a leading Employer of Record (EOR) and Professional Employer Organization (PEO) provider, today announced the appointment of David Epstein as Chief Operating Officer (COO), effective 1 January 2026
Dr.Abhay Kumar Pati, BAMS, MASF, Ph.d, D.Sc Physician, Researcher, Industrialist, Union City, C A 94587 Nutmeg offers benefits such as aiding digestion, promoting better sleep, and providing pain relief due to its anti-inflammatory and antioxidant...
Emerging biotech firm debuts "Science & Shield" initiative, bridging the gap between advanced medical research and immediate humanitarian relief for the Ozarks.
When it comes to sourcing high-quality clay materials for ceramics, pottery, and industrial applications, choosing a reliable ball clay supplier is essential.
Christie Schofield and Randy Herbertson bring leadership in healthcare access, innovation, and brand strategy to advance supportive cancer care nationwide.
The Herceptin Biosimilar Market is projected to grow from USD 2.9 billion in 2023 to USD 19.3 billion by 2032 at a CAGR of 23.6%, driven by expanding oncology treatment demand, biosimilar adoption, and healthcare affordability.
Biobase, a healthcare data infrastructure company pioneering the first agentic operating system for clinical data, received a strategic investment from BJC Health that will position BJC as a center of excellence for deploying next-generation AI solutions.
Platform delivers real-world evidence data for pharmaceutical research, hospital systems, insurance carriers, and senior living operators—achieving 87-91% accuracy in neurological disease detection
Bridging the orbital care gap: As NASA reassesses ISS medical protocols, Diopter Labs reveals a shelf-stable "clinic-in-a-lens" built to stop space-flight emergencies before they require evacuation.
CiRG Labs, a New York-based medical technology company, announced today a strategic partnership with Vinay Maheshwari to help grow the company's business and expand its clinical work globally.
SNS Intel is an Market Intelligence Platform for visual market intelligence across pharmaceutical and healthcare markets currently launching with Dermatology In Sight Module featuring in visual dashboards and Skin Cancer & Psoriasis as Focus areas
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP has Entered into a Joint Offering with neurocare Group for Neuroplastic Therapy Targeting Depression, PTSD and Other Mental Health Afflictions
Degenarative Cells required high value nutritional supplements for possible repairing and reconstruction. Dr. Abhay Kumar Pati, Natural Health Researcher, Author.
o2h Discovery, a preclinical contract research organization (CRO) with a fully integrated, multi-modality drug discovery platform, is pleased to announce the launch of the latest edition of the o2h Kickstarter in "North America." This program is...
The Antibody Production Market is forecast to grow from USD 17.3 billion in 2022 to USD 59.1 billion by 2032 at a CAGR of 13.2%, driven by increased R&D, chronic disease prevalence, and advancements in antibody technologies.
LactaLogics, a company focused on human milk-based nutrition for premature and at-risk infants, recently announced its new processing facility in Port St. Lucie is near completion.
The Oligonucleotide Synthesis Market is projected to grow from USD 7.4 billion in 2022 to USD 25.3 billion by 2032 at a CAGR of 13.3%, fueled by expanding therapeutic, diagnostic, and research applications.
183 views, By Bundelkhand Bio Power Private Limited
Bundelkhand Bio Power Private Limited has initiated an integrated renewable energy pilot project in Bilanda village of Fatehpur district, focusing on biogas, Bio-CNG and circular waste management solutions for rural sustainability.
The Metagenomics Market is projected to grow from USD 1.4 billion in 2022 to USD 5.2 billion by 2032 at a 14.5% CAGR, fueled by clinical, environmental, and biotech applications.
The Beta-carotene Market is projected to grow from USD 455 million in 2022 to USD 723 million by 2032, driven by demand from supplements, food fortification, and cosmetics.
The veteran led deep tech firm taps the renowned regulatory strategist and PharmaVoice 100 Honoree to architect the compliance framework for its re-dosable genetic medicines and solid state neural preservation systems.
The veteran led deep tech firm defines a new standard for optical computing, initiating the development of a proprietary differentiable physics kernel to solve the Non Linear Schrödinger Equation.
Newpage has announced a major expansion of its global delivery footprint with the launch of a new Chennai Newton Center, the expansion of its Bangalore Einstein Center, and plans to open a new office in Bristol in 2026.
Missouri Based Biotech Firm Reveals "Project AETHELGAARD"A Unified Physics Architecture capable of 1 Tbps Neural State Transfer and Geological Scale Data Preservation.
The Drug Discovery Market is projected to grow from USD 81.5 billion in 2022 to USD 181.4 billion by 2032 at a CAGR of 8.5%, driven by innovation and chronic disease research.
The Cancer Gene Therapy Market is forecast to reach USD 16.9 billion by 2032, growing at a 19.7% CAGR, driven by innovations in gene technologies and rising cancer treatment demand.
Data driven signal validates the company's "Failure Doctrine" operational model, positioning the Missouri based firm as a pre-seed outlier in the convergence of genomic medicine and optical computing.
VSee Health, Inc. (N A S D A Q: VSEE) $VSEE Reported Q3 Revenues Reach $3.98 Million, Up 19% Year-Over-Year with Clients Including NASA, U.S. Department of Health and Human Services, McKesson, DaVita and The Nation of Qatar
Metavalis OS introduces a self modifying, dual AI command center featuring military grade security, a 9 tier rank system, HIPAA EHR, and a meta conscious Singularity Engine for autonomous biotech operations.
